HRP20020346B1 - Ciclesonide contained pharmaceutical composition for application to mucosa - Google Patents

Ciclesonide contained pharmaceutical composition for application to mucosa

Info

Publication number
HRP20020346B1
HRP20020346B1 HR20020346A HRP20020346A HRP20020346B1 HR P20020346 B1 HRP20020346 B1 HR P20020346B1 HR 20020346 A HR20020346 A HR 20020346A HR P20020346 A HRP20020346 A HR P20020346A HR P20020346 B1 HRP20020346 B1 HR P20020346B1
Authority
HR
Croatia
Prior art keywords
application
pharmaceutical composition
mucosa
ciclesonide
contained pharmaceutical
Prior art date
Application number
HR20020346A
Other languages
English (en)
Croatian (hr)
Inventor
Nagano Atsuhiro
Nishibe Yoshihisa
Takanashi Kazuya
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020346(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of HRP20020346A2 publication Critical patent/HRP20020346A2/hr
Publication of HRP20020346B1 publication Critical patent/HRP20020346B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20020346A 1999-10-20 2002-04-19 Ciclesonide contained pharmaceutical composition for application to mucosa HRP20020346B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (2)

Publication Number Publication Date
HRP20020346A2 HRP20020346A2 (en) 2004-02-29
HRP20020346B1 true HRP20020346B1 (en) 2011-06-30

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020346A HRP20020346B1 (en) 1999-10-20 2002-04-19 Ciclesonide contained pharmaceutical composition for application to mucosa

Country Status (36)

Country Link
US (1) US6767901B1 (zh)
EP (1) EP1225902B1 (zh)
JP (1) JP4264211B2 (zh)
KR (1) KR100722209B1 (zh)
CN (2) CN1379674B (zh)
AR (1) AR026072A1 (zh)
AT (1) ATE285779T1 (zh)
AU (1) AU781895B2 (zh)
BG (1) BG65818B1 (zh)
BR (1) BRPI0014878B8 (zh)
CA (1) CA2388322C (zh)
CO (1) CO5261494A1 (zh)
CZ (1) CZ297779B6 (zh)
DE (1) DE60017175T2 (zh)
DK (1) DK1225902T3 (zh)
EA (1) EA006015B1 (zh)
ES (1) ES2234681T3 (zh)
HK (2) HK1050858A1 (zh)
HR (1) HRP20020346B1 (zh)
HU (1) HU228893B1 (zh)
IL (2) IL148691A0 (zh)
ME (1) ME00567B (zh)
MX (1) MXPA02003974A (zh)
MY (1) MY136987A (zh)
NO (1) NO327444B1 (zh)
NZ (1) NZ518298A (zh)
PE (1) PE20010712A1 (zh)
PL (1) PL199702B1 (zh)
PT (1) PT1225902E (zh)
RS (1) RS50310B (zh)
SI (1) SI1225902T1 (zh)
SK (1) SK286196B6 (zh)
TR (1) TR200200841T2 (zh)
TW (1) TWI225788B (zh)
WO (1) WO2001028562A1 (zh)
ZA (1) ZA200203077B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
BRPI0312377A8 (pt) 2002-07-02 2015-12-15 Altana Pharma Ag Suspensão aquosa estéril contendo ciclesonida
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
RU2343160C2 (ru) * 2002-07-26 2009-01-10 Фмк Корпорейшн Получение микрокристаллической целлюлозы
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
ATE405275T1 (de) * 2002-12-12 2008-09-15 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2265250A2 (en) * 2008-03-14 2010-12-29 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014473A1 (en) * 1991-02-23 1992-09-03 Fisons Ag Steroid formulations
WO1998052542A1 (en) * 1997-05-21 1998-11-26 Minnesota Mining And Manufacturing Company Medicinal aerosol products
WO1999025359A1 (en) * 1997-11-14 1999-05-27 Astrazeneca Ab New composition of matter
WO1999037286A1 (fr) * 1998-01-22 1999-07-29 Santen Pharmaceutical Co., Ltd. Collyre a suspension de fluorometholone
WO1999047144A1 (en) * 1998-03-17 1999-09-23 Pharmalink Basläkemedel Ab Method and means for treating glomerulonephritis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014473A1 (en) * 1991-02-23 1992-09-03 Fisons Ag Steroid formulations
WO1998052542A1 (en) * 1997-05-21 1998-11-26 Minnesota Mining And Manufacturing Company Medicinal aerosol products
WO1999025359A1 (en) * 1997-11-14 1999-05-27 Astrazeneca Ab New composition of matter
WO1999037286A1 (fr) * 1998-01-22 1999-07-29 Santen Pharmaceutical Co., Ltd. Collyre a suspension de fluorometholone
WO1999047144A1 (en) * 1998-03-17 1999-09-23 Pharmalink Basläkemedel Ab Method and means for treating glomerulonephritis

Also Published As

Publication number Publication date
BRPI0014878B1 (pt) 2015-08-11
JP2003512329A (ja) 2003-04-02
YU28002A (sh) 2004-11-25
TWI225788B (en) 2005-01-01
BG65818B1 (bg) 2010-01-29
DE60017175T2 (de) 2005-12-29
CO5261494A1 (es) 2003-03-31
BRPI0014878B8 (pt) 2021-05-25
MY136987A (en) 2008-12-31
PT1225902E (pt) 2005-05-31
ATE285779T1 (de) 2005-01-15
HU228893B1 (hu) 2013-06-28
MXPA02003974A (es) 2003-09-25
HK1149719A1 (en) 2011-10-14
HK1050858A1 (zh) 2003-07-11
IL148691A (en) 2006-12-10
US6767901B1 (en) 2004-07-27
NO327444B1 (no) 2009-06-29
NO20021898D0 (no) 2002-04-22
CN101869570A (zh) 2010-10-27
SK286196B6 (sk) 2008-05-06
BR0014878A (pt) 2002-06-11
CZ297779B6 (cs) 2007-03-28
CA2388322C (en) 2007-09-18
HUP0203339A3 (en) 2004-07-28
KR100722209B1 (ko) 2007-05-29
AU781895B2 (en) 2005-06-23
CN1379674B (zh) 2014-10-29
ME00567A (en) 2011-12-20
HUP0203339A2 (hu) 2003-02-28
EP1225902A1 (en) 2002-07-31
CN101869570B (zh) 2012-10-10
AR026072A1 (es) 2002-12-26
AU7953100A (en) 2001-04-30
NO20021898L (no) 2002-04-22
ME00567B (me) 2011-12-20
CZ20021238A3 (cs) 2002-07-17
DK1225902T3 (da) 2005-05-02
BG106512A (bg) 2002-12-29
DE60017175D1 (de) 2005-02-03
PE20010712A1 (es) 2001-07-12
RS50310B (sr) 2009-09-08
ZA200203077B (en) 2003-02-26
NZ518298A (en) 2003-11-28
JP4264211B2 (ja) 2009-05-13
IL148691A0 (en) 2002-09-12
EP1225902B1 (en) 2004-12-29
TR200200841T2 (tr) 2002-07-22
SI1225902T1 (en) 2005-06-30
WO2001028562A1 (en) 2001-04-26
EA006015B1 (ru) 2005-08-25
CA2388322A1 (en) 2001-04-26
EA200200375A1 (ru) 2002-10-31
PL356191A1 (en) 2004-06-14
CN1379674A (zh) 2002-11-13
ES2234681T3 (es) 2005-07-01
HRP20020346A2 (en) 2004-02-29
SK6922002A3 (en) 2002-09-10
PL199702B1 (pl) 2008-10-31
KR20020059627A (ko) 2002-07-13

Similar Documents

Publication Publication Date Title
HRPK990402B1 (hr) Farmaceutski pripravci za primjenu na sluznici
HRP20020346B1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
HRP20010463B1 (en) Controlled release galantamine composition
HRP20020880B1 (en) New pharmaceutical composition
HRP20020090B1 (hr) FARMACEUTSKI PRIPRAVCI S Ăź-KARBOLINOM
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
YU53098A (sh) Preparat koncentrovanog antitela
ME00568B (me) Vodena farmaceutska kompozicija koja sadrži ciklesonid
JPS57118509A (en) Novel preparation of high absorbability
TH56262B (th) สารผสมทางเภสัชกรรมที่มีคลีโซไนด์สำหรับการใช้ที่เยื่อบุ
MY124416A (en) Pharmaceutical composition for application to mucosa
CR6122A (es) Composicion farmaceutica para ser aplicada a las mucosas

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GMBH, DE

B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: TAKEDA GMBH, DE

PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GERMANY HOLDING GMBH, DE

Owner name: NYCOMED ASSET MANAGEMENT GMBH, DE

Owner name: TAKEDA GMBH, DE

PPPP Transfer of rights

Owner name: ASTRAZENECA AB, SE

PPPP Transfer of rights

Owner name: COVIS PHARMA B.V., CH

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190828

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20201020